tirzepatide cardiovascular outcomes study Comparative efficacy of and glucagon-like peptide-1 receptor agonists on in patients with type 2 diabetes: a systematic review and network meta-analysis | Cardiovascular Diabetology UC Irvine researchers project cardiac

In preclinical binding studies, it binds GIPR with higher affinity than GLP-1R roughly equivalent to native GIP while maintaining meaningful GLP-1R activity

Can partial dosing or click counting be used for maintenance

At the 2023 ADA Scientific Sessions in San Diego this week, researchers unveiled full results of the SURMOUNT-2 clinical trial evaluating tirzepatide for weight loss in adults with obesity or overweight and type 2 diabetes

For example, dose-dependent inhibition of NADH-linked respiration has been reported under AZT administration across multiple tested tissues

Xuan et al., 2016)

Some studies have also indicated potential roles in cartilage regeneration and immune-related pathways